Keros Therapeutics (KROS) Cash from Investing Activities Growth (1y) (2020 - 2025)
Keros Therapeutics (KROS) Cash from Investing Activities Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Keros Therapeutics |
378.54 Mn |
91.14 Mn |
- |
53.63% |
| Date | Value |
|---|
| Dec 31, 2025 |
53.63% |
| Sep 30, 2025 |
65.80% |
| Jun 30, 2025 |
-132.26% |
| Mar 31, 2025 |
40.27% |
| Dec 31, 2024 |
46.58% |
| Sep 30, 2024 |
29.82% |
| Jun 30, 2024 |
0.32% |
| Mar 31, 2024 |
10.92% |
| Dec 31, 2023 |
-54.13% |
| Sep 30, 2023 |
-212.50% |
| Jun 30, 2023 |
45.15% |
| Mar 31, 2023 |
-622.45% |
| Dec 31, 2022 |
-120.75% |
| Sep 30, 2022 |
-21.38% |
| Jun 30, 2022 |
-11.18% |
| Mar 31, 2022 |
30.00% |
| Dec 31, 2021 |
-165.00% |
| Sep 30, 2021 |
-383.33% |
| Jun 30, 2021 |
-1,721.43% |
| Mar 31, 2021 |
-19.32% |
